4//SEC Filing
Falconer Ester 4
Accession 0001209191-21-054749
CIK 0001703057other
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 4:18 PM ET
Size
7.1 KB
Accession
0001209191-21-054749
Insider Transaction Report
Form 4
Falconer Ester
Chief Technology Officer
Transactions
- Exercise/Conversion
Common Shares
2021-09-01$16.89/sh+875,000$14,778,750→ 875,000 total - Exercise/Conversion
Share option (right to buy)
2021-09-01−875,000→ 875,000 totalExercise: $0.31Exp: 2029-01-01→ Common Shares (875,000 underlying)
Footnotes (1)
- [F1]The shares subject to such option vest and become exercisable annually in substantially equal installments over a three-year period, with the first tranche vested on January 1, 2020, subject to the Reporting Person's continuous service to the Issuer on each such date
Documents
Issuer
AbCellera Biologics Inc.
CIK 0001703057
Entity typeother
Related Parties
1- filerCIK 0001844479
Filing Metadata
- Form type
- 4
- Filed
- Sep 2, 8:00 PM ET
- Accepted
- Sep 3, 4:18 PM ET
- Size
- 7.1 KB